Colab CIRS Biomarker Panel
This comprehensive panel measures critical inflammatory hormones and immune markers including MMP9, TGF Beta-1, C4a (elevated), MSH, VIP, VEGF (decreased), and includes HLA genetic testing and MARCoNS nasal swab analysis. The test follows the validated Shoemaker Protocol and is the only Apollo Health-validated Bredesen panel available in Europe. Target users include patients with environmental illness, mold exposure, biotoxin illness, CIRS, and post-COVID syndrome, particularly those with genetic susceptibility (25% of population with HLA gene variants). The testing provides essential biomarkers for proper diagnosis and treatment monitoring according to established biotoxin illness protocols.
